Therapeutic BCL11A enhancer gene editing to induce fetal hemoglobin in ?-hemoglobinopathy patients - no abstract provided

Ended Project Grant Awarded Last action

Award ID
OT2HL154984
Recipient
Awarding agency
Obligated
$886,788

Award facts

Assistance listing
93.839 Blood Diseases and Resources Research
Completion date
Place of performance
Boston, MA 02115, USA

Award details come from USAspending.gov.

Quick answers

Who received award OT2HL154984?

OT2HL154984 was awarded to The Children's Hospital Corporation by National Heart Lung and Blood Institute (National Institutes of Health) on June 18, 2020.

How much is award OT2HL154984 worth?

$886,788 has been obligated on OT2HL154984.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award